|
It's a message in a name; one that inspires our development and progress as a
centre.
By working together, the centre promises much for brain research at the University, for clinical care
in our hospitals and for enhanced treatment for people affected by brain disease.
It's estimated that one in five New Zealanders will suffer from brain disease in
their lifetimes. Disorders such as stroke, epilepsy, Alzheimer's, Parkinson's, Huntington's,
motor neurone disease, multiple sclerosis, muscular dystrophy and deafness affect hundreds of thousands
of New Zealanders every year. Neurological diseases are among the top five most
common causes of death and long-term disability. The cost to families and society,
both financially and socially, is enormous.
That's where the breadth and scope of the three pillars of the
centre will prove
invaluable; our unique partnership between scientists, doctors and the community.
Our combined, complementary expertise and knowledge will be a powerful
force to address the challenges of neurological disease.
|
L-R:
Professor Alan Barber, Deputy Director, CBR and Professor Richard Faull, Director,
CBR
|
